MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI ...
International Clinical Trials Day marked the anniversary of the very first clinical trial conducted by James Lind on board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results